Loading clinical trials...

Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes | Clinical Trials | Clareo Health

COMPLETEDPHASE2/PHASE3

Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes

Effect of Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes

NCT00499148•Abbott Nutrition

View on ClinicalTrials.gov

Summary

The purpose of the study was to evaluate the effect of an herbal extract on postprandial glycemia following a meal.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•type 2 diabetes
•Between 18 and 75 years of age
•Male or non-pregnant, non-lactating female, at least 6 weeks postpartum
•If of childbearing potential, is practicing birth control
•BMI is more than or equal to 18kg/m2 and less than or equal to 35kg/m2
•If on anti-hyperglycemic, anti-hypertensive, lipid-lowering, or thyroid medications or hormone therapy, has been on constant dosage for at least 3 months prior to screening visit

Exclusion Criteria

•Uses insulin for glucose control or has type 1 diabetes
•History of diabetic ketoacidosis.
•Current infection; surgery or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks.
•Active malignancy
•Significant cardiovascular event less than or equal to 6 months prior to screening visit or history of congestive heart failure
•End state organ failure or status post organ transplant
•History of renal disease
•Current hepatic disease
•History of severe gastroparesis
•Has a chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV
+3 more criteria

Locations (2)

Radiant Research

Edina, Minnesota, United States

Radiant Research

Cincinnati, Ohio, United States

Key Dates

Start Date

August 1, 2006

Primary Completion Date

August 1, 2007

Completion Date

October 1, 2007

Last Updated

July 30, 2010

Enrollment

ACTUAL participants

Conditions

Type 2 Diabetes

Interventions

herbal extract; root of woody shrub grown in India/Sri-Lanka

OTHER

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005

Type 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

View study

RECRUITINGPHASE2

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

NCT07296484

Type 2 DiabetesCortisol Excess

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 30, 2010Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes

Inclusion Criteria

Exclusion Criteria

Feasibility of a Tailored Online Self-compassion Intervention

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

iGlarLixi CGM Study in Chinese T2D Individuals After OADs

High Intensity Interval Training and Insulin Sensitivity in Type 2 Diabetes

SGLT2i, Pioglitazone, and Ketone Production in T2D

Closed-loop in Adults With Type 2 Diabetes